Cystic Fibrosis Foundation Therapeutics Inc. (CFFT), the nonprofit affiliate of the Cystic Fibrosis Foundation, announced today a $3 million agreement with Anthera Pharmaceuticals Inc. to develop a porcine-free pancreatic enzyme therapy, liprotamase, for people with CF who have pancreatic insufficiency.